Fulgent Genetics offers one of the world’s largest portfolios of clinical genetic and genomic tests, allowing us to serve an expanding and diverse patient population. At our high-throughput CLIA-certified/CAP-accredited facility, we continuously innovate and develop new solutions to ensure that we can meet the increasing and varying needs of clinicians and their patients, and improve diagnostic outcomes. Offering everything from NGS to pathology to multiomic discovery services, we leverage a tremendous expertise in NGS and clinical genetics to provide reliable and superior support for our pharma, biotech and clinical trial partners.

For more details on our offerings, please visit us at: https://labs.fulgentgenetics.com/